![]() | Up a level |
Schuh, Anna H, Parry-Jones, Nilima, Appleby, Niamh, Bloor, Adrian, Dearden, Claire E, Fegan, Christopher, Follows, George, Fox, Christopher P, Iyengar, Sunil, Kennedy, Ben et al (show 7 more authors)
(2018)
Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline.
BRITISH JOURNAL OF HAEMATOLOGY, 182 (3).
pp. 344-359.
Hillmen, Peter, Rawstron, Andy C, Brock, Kristian, Muñoz-Vicente, Samuel, Yates, Francesca J, Bishop, Rebecca, Boucher, Rebecca, MacDonald, Donald, Fegan, Christopher, McCaig, Alison et al (show 9 more authors)
(2019)
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study.
Journal of Clinical Oncology, 37 (30).
pp. 2722-2730.
Pettitt, Andrew R, Jackson, Richard, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Polydoros, Fotis, Yap, Christina, Dodd, James, Bickerstaff, Matthew, Stackpoole, Michael, Khan, Umair T
ORCID: 0000-0002-9470-3481, Carruthers, Stacey et al (show 16 more authors)
(2020)
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial.
HAEMATOLOGICA, 105 (12).
pp. 2868-2871.